These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18760600)

  • 41. Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.
    Thomson SA; Banker P; Bickett DM; Boucheron JA; Carter HL; Clancy DC; Cooper JP; Dickerson SH; Garrido DM; Nolte RT; Peat AJ; Sheckler LR; Sparks SM; Tavares FX; Wang L; Wang TY; Weiel JE
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1177-82. PubMed ID: 19138846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nicotinic acid receptor subtypes and their ligands.
    Soudijn W; van Wijngaarden I; Ijzerman AP
    Med Res Rev; 2007 May; 27(3):417-33. PubMed ID: 17238156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Discovery of potential nicotinic acid receptor agonists from Chinese herbal medicines based on molecular simulation].
    Jiang LD; He YS; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(23):4653-7. PubMed ID: 25911818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
    Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B
    J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist.
    Tang H; Lu JY; Zheng X; Yang Y; Reagan JD
    Biochem Biophys Res Commun; 2008 Oct; 375(4):562-5. PubMed ID: 18722346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
    Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F
    J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and solid-phase purification of anthranilic sulfonamides as CCK-2 ligands.
    Woods CR; Hack MD; Allison BD; Phuong VK; Rosen MD; Morton MF; Prendergast CE; Barrett TD; Shankley NP; Rabinowitz MH
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6905-9. PubMed ID: 18029172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6/4beta4 nicotinic receptor agonists.
    Lowe JA; DeNinno SL; Coe JW; Zhang L; Mente S; Hurst RS; Mather RJ; Ward KM; Shrikhande A; Rollema H; Johnson DE; Horner W; Gorczyca R; Tingley FD; Kozak R; Majchrzak MJ; Tritto T; Sadlier J; Shaffer CL; Ellerbrock B; Osgood SM; MacDougall MC; McDowell LL
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4749-52. PubMed ID: 20663668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid.
    Pike NB
    J Clin Invest; 2005 Dec; 115(12):3400-3. PubMed ID: 16322787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b.
    Skinner PJ; Webb PJ; Sage CR; Dang TH; Pride CC; Chen R; Tamura SY; Richman JG; Connolly DT; Semple G
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4207-9. PubMed ID: 19524438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-activity relationships of N-substituted ligands for the alpha7 nicotinic acetylcholine receptor.
    Mortell KH; Schrimpf MR; Bunnelle WH; Anderson DJ; Gronlien JH; Hagene KT; Gopalakrishnan M
    Bioorg Med Chem Lett; 2010 Jan; 20(1):104-7. PubMed ID: 19954975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A model for short alpha-neurotoxin bound to nicotinic acetylcholine receptor from Torpedo californica: comparison with long-chain alpha-neurotoxins and alpha-conotoxins.
    Mordvintsev DY; Polyak YL; Levtsova OV; Tourleigh YV; Kasheverov IE; Shaitan KV; Utkin YN; Tsetlin VI
    Comput Biol Chem; 2005 Dec; 29(6):398-411. PubMed ID: 16290328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alpha7 nicotinic acetylcholine receptor agonists: prediction of their binding affinity through a molecular mechanics Poisson-Boltzmann surface area approach.
    Grazioso G; Cavalli A; De Amici M; Recanatini M; De Micheli C
    J Comput Chem; 2008 Nov; 29(15):2593-602. PubMed ID: 18478580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel 3,6,7-substituted pyrazolopyrimidines as positive allosteric modulators for the hydroxycarboxylic acid receptor 2 (GPR109A).
    Blad CC; van Veldhoven JP; Klopman C; Wolfram DR; Brussee J; Lane JR; Ijzerman AP
    J Med Chem; 2012 Apr; 55(7):3563-7. PubMed ID: 22420767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impedance measurement: a new method to detect ligand-biased receptor signaling.
    Kammermann M; Denelavas A; Imbach A; Grether U; Dehmlow H; Apfel CM; Hertel C
    Biochem Biophys Res Commun; 2011 Sep; 412(3):419-24. PubMed ID: 21827738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Triglyceride modulation by acifran analogs: activity towards the niacin high and low affinity G protein-coupled receptors HM74A and HM74.
    Mahboubi K; Witman-Jones T; Adamus JE; Letsinger JT; Whitehouse D; Moorman AR; Sawicki D; Bergenhem N; Ross SA
    Biochem Biophys Res Commun; 2006 Feb; 340(2):482-90. PubMed ID: 16389067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
    Holladay MW; Dart MJ; Lynch JK
    J Med Chem; 1997 Dec; 40(26):4169-94. PubMed ID: 9435889
    [No Abstract]   [Full Text] [Related]  

  • 59. Architecture of the human urotensin II receptor: comparison of the binding domains of peptide and non-peptide urotensin II agonists.
    Lavecchia A; Cosconati S; Novellino E
    J Med Chem; 2005 Apr; 48(7):2480-92. PubMed ID: 15801838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A).
    Kostylina G; Simon D; Fey MF; Yousefi S; Simon HU
    Cell Death Differ; 2008 Jan; 15(1):134-42. PubMed ID: 17932499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.